Regeneus Ltd (ASX:RGS)
Share Price and News
Founded in 2007, Regeneus Ltd (ASX: RGS) is a Sydney-based regenerative medicine company involved in developing therapeutic products and cellular therapies using proprietary stem cell and immunotherapy technologies. Its work focusses on osteoarthritis, musculoskeletal disorders, cancer, oncology, dermatology and chronic pain. Its product under development for human care includes Progenza – leading cell therapy, RGSH4K – cancer vaccine and Sygenus – acne treatment and the animal care product line includes CryoShot.